Qurexa Logo
Qurexa

Trust. Care. Deliver.

Back to Blog & Insights
Technology

Stem cells given a week after a stroke rebuilt damaged brain in mice

Qurexa Editorial Team22 September 20266 min read 0 0
Stem cells given a week after a stroke rebuilt damaged brain in mice

What happened

Scientists in Switzerland have transplanted human stem cells into the brains of mice that had suffered a stroke. Five weeks later, the damaged areas had partly rebuilt themselves, and the mice were walking properly again. The work was done at the University of Zurich, led by Christian Tackenberg and Rebecca Weber. It was published in the journal Nature Communications and reported on 21 September 2026. Here is what the team did. They started with induced pluripotent stem cells. These are ordinary human cells, usually skin or blood cells, that have been reprogrammed in the laboratory so they can become almost any cell type. From those, they made neural stem cells, the kind that can turn into brain cells. They then gave mice a stroke under controlled laboratory conditions. One week later, they transplanted the human cells into the damaged part of the brain. The mice were genetically modified so their immune systems would not reject human cells. Researchers then tracked what happened over five weeks, using imaging and biochemical analysis. The results were more wide-ranging than expected. The transplanted cells survived the whole five weeks. Most of them turned into working neurons, and those neurons connected into the existing brain tissue rather than sitting there as a separate lump. But the repair went further than new nerve cells. New blood vessels formed in the damaged area. Inflammation went down. The blood-brain barrier, the protective filter between the bloodstream and the brain, became less leaky. And the mice recovered movement. Motor problems caused by the stroke were reversed, measured partly by using artificial intelligence to analyse walking patterns in fine detail. As one of the researchers put it: "Our findings show that neural stem cells not only form new neurons, but also induce other regeneration processes."

Why this matters

Stroke is one of the biggest causes of disability in the UK. Every year, tens of thousands of people are left with lasting difficulty walking, speaking or using an arm. Current treatment is mostly about the first few hours. Clot-busting drugs and clot removal can limit the damage if they are given fast enough. After that window closes, there is rehabilitation, which genuinely helps, but there is nothing that repairs brain tissue that has already died. That is the gap this research is aiming at. One detail stands out as unusually practical. The cells were transplanted a week after the stroke, not immediately. And the delay was not a compromise: waiting a week worked better than treating straight away. That matters enormously for real-world use. A treatment that must be given within hours reaches only the people who get to the right hospital fast. A treatment with a week's window could reach almost everyone. The other interesting finding is that the benefit did not come only from replacing lost neurons. The transplanted cells seemed to change the environment around them: calming inflammation, encouraging blood vessels, repairing the barrier. That suggests stem cells may work partly as a signal to the brain's own repair systems, not just as spare parts.

What the evidence actually says

This is a mouse study. That single sentence should sit alongside everything else here. Mouse strokes are induced deliberately, in young healthy animals, under controlled conditions. Human strokes happen unpredictably, usually in older people, often alongside high blood pressure, diabetes or heart disease. The brain is also far larger and more complex, and damaged areas are correspondingly bigger. The history of stroke research is full of treatments that worked in rodents and failed in people. That is not a reason to dismiss this work. It is a reason to be precise about what it shows. The immune point is significant too. These mice were genetically modified so they would not reject human cells. Real patients would reject them, unless the cells were made from the patient's own cells, which is slow and expensive, or unless immune-suppressing drugs were used, which carry their own risks. Safety is the other open question. Pluripotent stem cells can, in principle, form tumours if any undifferentiated cells remain. Five weeks is not long enough to rule that out. The researchers say they are developing safety mechanisms, along with less invasive ways of delivering the cells, before any human trial. One of the team said "stroke could be one of the next diseases for which a clinical trial becomes possible". Read that carefully. It says a trial may become possible, not that a treatment exists. The measurement work is a genuine strength. Using AI to analyse gait picks up differences a human observer would miss, which makes the recovery finding more solid than a simple pass-or-fail test.

Practical advice

Nothing in this study changes stroke care today. But stroke itself is one of the conditions where what you do in the moment matters most, so it is worth repeating the basics. Learn the FAST test. Face drooping on one side. Arms, can the person lift both and keep them up. Speech, is it slurred or muddled. Time, if you see any of these, call 999 immediately. Do not wait to see if it passes. Treatment that limits stroke damage works best within hours. Delay is the single biggest reason people miss it. On prevention, the strongest lever is blood pressure. High blood pressure is the biggest single risk factor for stroke, and it usually causes no symptoms at all. Getting it checked is free and takes minutes. Many pharmacies in England offer blood pressure checks without an appointment. If you have been prescribed blood pressure tablets, blood thinners or a statin after a stroke or mini-stroke, taking them consistently is one of the most effective things you can do. This is the part that is easy to let slip once you feel better. Finally, be very wary of clinics abroad offering stem cell treatment for stroke. These are not the same as the research described here. They are unproven, sometimes dangerous, and often very expensive. There is no approved stem cell treatment for stroke anywhere.

What to know

Researchers at the University of Zurich transplanted human neural stem cells into mice one week after a stroke. Over five weeks the cells survived, became working neurons and integrated into existing tissue. The repair went beyond new nerve cells. New blood vessels formed, inflammation fell, and the blood-brain barrier improved. The mice regained lost movement. Treating after a week's delay worked better than treating immediately, which would make any future treatment far more practical to deliver. This is animal research. The mice were genetically modified to accept human cells, the study lasted five weeks, and tumour safety has not been established. No human trial has begun, and stroke research has a long history of mouse results that did not carry over. For now, the things that actually protect you are unchanged: know the FAST signs, call 999 fast, and keep blood pressure under control. Sources: ScienceDaily, "Stem cells reverse stroke damage and restore movement in mice", 21 September 2026, https://www.sciencedaily.com/releases/2026/09/260921081116.htm; Weber, R. and Tackenberg, C. et al., Nature Communications, https://doi.org/10.1038/s41467-025-63725-3; University of Zurich, https://www.uzh.ch/en.html This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional. If you think someone is having a stroke, call 999 straight away.

#stroke#stem cells#brain repair#regenerative medicine#research#neuroscience

Related articles